[Clinical characteristics and prognostic analysis of newly diagnosed acute myeloid leukemia with critical illness].

Q3 Medicine
P Q Liang, M Gao, Y Xie, B Q Li, Q Li, Z Y Liu, D Wang, H Y Qiu, S N Chen, D P Wu, J H Fu
{"title":"[Clinical characteristics and prognostic analysis of newly diagnosed acute myeloid leukemia with critical illness].","authors":"P Q Liang, M Gao, Y Xie, B Q Li, Q Li, Z Y Liu, D Wang, H Y Qiu, S N Chen, D P Wu, J H Fu","doi":"10.3760/cma.j.cn121090-20241211-00561","DOIUrl":null,"url":null,"abstract":"<p><p><b>Objective:</b> This study retrospectively analyzed the clinical characteristics of patients newly diagnosed with acute myeloid leukemia (AML) who were admitted to the hematology intensive care unit (HCU) with critical illness. It also examined factors associated with critical illness and early mortality in these patients. <b>Methods:</b> Clinical data were collected from 91 newly diagnosed AML patients admitted to the HCU of the Department of Hematology, First Affiliated Hospital of Soochow University, from October 2020 to 2024. Reasons for HCU admission, major therapeutic interventions, and risk factors for critical illness and early mortality were analyzed. <b>Results:</b> The median time from diagnosis to HCU admission was 3 days (<i>IQR</i>: 3-9 days), and the median HCU stay was 10 days (<i>IQR</i>: 3-23 days). Of the 91 patients, 71 were admitted to the HCU before induction chemotherapy, while 20 were transferred to the HCU after its initiation. The leading causes of HCU admission were pulmonary infection (78.0% ), respiratory failure (44.0% ), hepatic insufficiency (28.6% ), renal insufficiency (27.5% ), disseminated intravascular coagulation (DIC; 25.3% ), and sepsis (23.1% ). Median Acute Physiology and Chronic Health Evaluation Ⅱ (APACHE Ⅱ) and SOFA scores at HCU admission were 14 (<i>IQR</i>: 11-18) and the median Sepsis Related Organ Failure Assessment (SOFA) score was 7 (<i>IQR</i>: 4, 10). Major HCU interventions included vasoactive drugs, noninvasive and invasive mechanical ventilation, continuous renal replacement therapy, therapeutic leukocyte clearance, and cardiopulmonary resuscitation. Among patients receiving induction chemotherapy, the composite complete remission rate was 65.4%, and the overall remission rate was 88.5%. Thirty-five (38.5% ) patients died within 28 days of HCU admission. Independent risk factors for 28-day mortality were DIC (<i>OR</i>=9.350, 95% <i>CI</i> 1.999-43.745, <i>P</i>=0.005), sepsis (<i>OR</i>=6.817, 95% <i>CI</i> 1.571-29.582, <i>P</i>=0.010), and cardiac insufficiency (<i>OR</i>=12.281, 95% <i>CI</i> 2.385-63.254, <i>P</i>=0.003) . <b>Conclusion:</b> The main reason for HCU admission in newly diagnosed critically ill AML patients was pulmonary infection. Nearly 40% of patients experisenced early death, and DIC, sepsis, and heart failure were factors influencing early mortatlity.</p>","PeriodicalId":24016,"journal":{"name":"Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi","volume":"46 1","pages":"39-44"},"PeriodicalIF":0.0000,"publicationDate":"2025-01-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11886432/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.3760/cma.j.cn121090-20241211-00561","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0

Abstract

Objective: This study retrospectively analyzed the clinical characteristics of patients newly diagnosed with acute myeloid leukemia (AML) who were admitted to the hematology intensive care unit (HCU) with critical illness. It also examined factors associated with critical illness and early mortality in these patients. Methods: Clinical data were collected from 91 newly diagnosed AML patients admitted to the HCU of the Department of Hematology, First Affiliated Hospital of Soochow University, from October 2020 to 2024. Reasons for HCU admission, major therapeutic interventions, and risk factors for critical illness and early mortality were analyzed. Results: The median time from diagnosis to HCU admission was 3 days (IQR: 3-9 days), and the median HCU stay was 10 days (IQR: 3-23 days). Of the 91 patients, 71 were admitted to the HCU before induction chemotherapy, while 20 were transferred to the HCU after its initiation. The leading causes of HCU admission were pulmonary infection (78.0% ), respiratory failure (44.0% ), hepatic insufficiency (28.6% ), renal insufficiency (27.5% ), disseminated intravascular coagulation (DIC; 25.3% ), and sepsis (23.1% ). Median Acute Physiology and Chronic Health Evaluation Ⅱ (APACHE Ⅱ) and SOFA scores at HCU admission were 14 (IQR: 11-18) and the median Sepsis Related Organ Failure Assessment (SOFA) score was 7 (IQR: 4, 10). Major HCU interventions included vasoactive drugs, noninvasive and invasive mechanical ventilation, continuous renal replacement therapy, therapeutic leukocyte clearance, and cardiopulmonary resuscitation. Among patients receiving induction chemotherapy, the composite complete remission rate was 65.4%, and the overall remission rate was 88.5%. Thirty-five (38.5% ) patients died within 28 days of HCU admission. Independent risk factors for 28-day mortality were DIC (OR=9.350, 95% CI 1.999-43.745, P=0.005), sepsis (OR=6.817, 95% CI 1.571-29.582, P=0.010), and cardiac insufficiency (OR=12.281, 95% CI 2.385-63.254, P=0.003) . Conclusion: The main reason for HCU admission in newly diagnosed critically ill AML patients was pulmonary infection. Nearly 40% of patients experisenced early death, and DIC, sepsis, and heart failure were factors influencing early mortatlity.

新诊断急性髓系白血病伴危重症的临床特点及预后分析
目的:回顾性分析血液科重症监护病房(HCU)新诊断急性髓系白血病(AML)危重症患者的临床特点。它还研究了与这些患者的危重疾病和早期死亡有关的因素。方法:收集2020年10月至2024年10月苏州大学第一附属医院血液科HCU收治的91例新诊断AML患者的临床资料。分析HCU入院的原因、主要治疗干预措施、危重疾病和早期死亡的危险因素。结果:从诊断到入住HCU的中位时间为3天(IQR: 3-9天),HCU住院的中位时间为10天(IQR: 3-23天)。91例患者中,71例在诱导化疗前入住HCU, 20例在诱导化疗开始后转入HCU。HCU入院的主要原因是肺部感染(78.0%)、呼吸衰竭(44.0%)、肝功能不全(28.6%)、肾功能不全(27.5%)、弥散性血管内凝血(DIC;25.3%),败血症(23.1%)。入院时急性生理和慢性健康评估Ⅱ(APACHEⅡ)和SOFA评分中位数为14分(IQR: 11-18),脓毒症相关器官衰竭评估(SOFA)评分中位数为7分(IQR: 4,10)。主要的HCU干预措施包括血管活性药物、无创和有创机械通气、持续肾脏替代治疗、治疗性白细胞清除和心肺复苏。在接受诱导化疗的患者中,综合完全缓解率为65.4%,总缓解率为88.5%。35例(38.5%)患者在HCU入院28天内死亡。28天死亡率的独立危险因素为DIC (OR=9.350, 95% CI 1.999-43.745, P=0.005)、脓毒症(OR=6.817, 95% CI 1.571-29.582, P=0.010)和心功能不全(OR=12.281, 95% CI 2.385-63.254, P=0.003)。结论:新诊断急性髓系白血病危重患者入院的主要原因是肺部感染。近40%的患者经历了早期死亡,DIC、败血症和心力衰竭是影响早期死亡率的因素。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
0.80
自引率
0.00%
发文量
100
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信